Chitosan and its salts for mucosal and transmucosal delivery.
about
Structural and Functional Analysis of the Complex between Citrate and the Zinc Peptidase Carboxypeptidase ARecent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents.Liposomes as delivery systems for nasal vaccination: strategies and outcomes.Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.Advances in using chitosan-based nanoparticles for in vitro and in vivo drug and gene delivery.Chitosan nanoparticles: a survey of preparation methods.Marine polysaccharides in microencapsulation and application to aquaculture: "from sea to sea".Advances in oral macromolecular drug delivery.Enhancing the buccal mucosal delivery of peptide and protein therapeutics.Polymer coated liposomes for use in the oral cavity - a study of the in vitro toxicity, effect on cell permeability and interaction with mucin.Ultra-small algal chitosan ocular nanoparticles with iron-binding milk protein prevents the toxic effects of carbendazim pesticide.Chitosan-based intragastric delivery of cefuroxime axetil: development and in-vitro evaluation of mucoadhesive approach.Improvement of dissolution behavior of poorly water soluble drugs by biodegradable polymeric submicron carriers containing sparingly methylated β-cyclodextrin.Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin Wounds.Topical ophthalmic lipid nanoparticle formulations (SLN, NLC) of indomethacin for delivery to the posterior segment ocular tissues.Quaternary Salts of Chitosan: History, Antimicrobial Features, and Prospects
P2860
Q27671316-737B2A60-8D1D-4CE5-83F1-29A57A28402EQ34733812-394361AB-FBA1-41F9-8055-13471A219025Q37748791-FCE37F62-53BE-4CD0-96EE-4D992DFCB26DQ37766235-D3AC387D-21DB-471E-8213-94E5F45E8DFCQ37788222-63D07226-8DA7-44A7-9ACB-48756FA3F3ACQ37980520-B44A5D0B-6D9D-4DFC-A864-2435D1FC39FCQ37987912-BCCD71D8-0B00-4304-A1FA-030435689F53Q38235506-2CEB79AA-FB33-44B6-B068-1713A0566B72Q38244323-B5F7C0EF-6411-42C3-8C26-F8F4EA399B67Q38733264-C0263BAB-ACB5-4ECD-93B1-7CF1D68E0E94Q38809370-3E09CB35-850C-41CA-B6D7-6952289ADF06Q43690103-320277A5-04EC-491F-9F91-DD80BAB23A5DQ44132839-DD691A2A-1A12-4FD5-8446-0DC08669BE0BQ50099665-7274E0DD-9117-41CB-97BE-3DCA7C75CE27Q50278439-C679155A-3E54-41EA-99FA-56D5C37CFA19Q58655849-B58BAC2D-C4F8-4269-BED9-981D25B8B215
P2860
Chitosan and its salts for mucosal and transmucosal delivery.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chitosan and its salts for mucosal and transmucosal delivery.
@en
Chitosan and its salts for mucosal and transmucosal delivery.
@nl
type
label
Chitosan and its salts for mucosal and transmucosal delivery.
@en
Chitosan and its salts for mucosal and transmucosal delivery.
@nl
prefLabel
Chitosan and its salts for mucosal and transmucosal delivery.
@en
Chitosan and its salts for mucosal and transmucosal delivery.
@nl
P2093
P2860
P1476
Chitosan and its salts for mucosal and transmucosal delivery.
@en
P2093
Carla Caramella
Franca Ferrari
Silvia Rossi
P2860
P304
P356
10.1517/17425240903114142
P407
P577
2009-09-01T00:00:00Z